 |
Previous Article | Next Article 
The Journal of Neuroscience, July 15, 1998, 18(14):5508-5516
Mice Lacking Ataxin-1 Display Learning Deficits and Decreased
Hippocampal Paired-Pulse Facilitation
Antoni
Matilla1,
Erik
D.
Roberson2,
Sandro
Banfi1,
Joanella
Morales3,
Dawna L.
Armstrong4,
Eric N.
Burright7,
Harry T.
Orr7,
John D.
Sweatt2,
Huda Y.
Zoghbi1, 2, 3, 6, and
Martin M.
Matzuk3, 4, 5
Departments of 1 Pediatrics,
2 Neuroscience, 3 Molecular and Human Genetics,
4 Pathology, and 5 Cell Biology, and
6 Howard Hughes Medical Institute, Baylor College of
Medicine, Houston, Texas 77030, and 7 University of
Minnesota, Minneapolis, Minnesota 55455
Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative
disorder characterized by ataxia, progressive motor deterioration, and
loss of cerebellar Purkinje cells. To investigate SCA1 pathogenesis and
to gain insight into the function of the SCA1 gene
product ataxin-1, a novel protein without homology to previously
described proteins, we generated mice with a targeted deletion in the
murine Sca1 gene. Mice lacking ataxin-1 are viable,
fertile, and do not show any evidence of ataxia or neurodegeneration.
However, Sca1 null mice demonstrate decreased
exploratory behavior, pronounced deficits in the spatial version of the
Morris water maze test, and impaired performance on the rotating rod
apparatus. Furthermore, neurophysiological studies performed in area
CA1 of the hippocampus reveal decreased paired-pulse facilitation in
Sca1 null mice, whereas long-term and post-tetanic
potentiations are normal. These findings demonstrate that SCA1 is not
caused by loss of function of ataxin-1 and point to the possible role
of ataxin-1 in learning and memory.
Key words:
spinocerebellar ataxia type 1; ataxin-1; neurobehavior; hippocampus; cerebellum; paired-pulse facilitation
Copyright © 1998 Society for Neuroscience 0270-6474/98/18145508-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
J. Shao and M. I. Diamond
Polyglutamine diseases: emerging concepts in pathogenesis and therapy
Hum. Mol. Genet.,
October 15, 2007;
16(R2):
R115 - R123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Goold, M. Hubank, A. Hunt, J. Holton, R. P. Menon, T. Revesz, M. Pandolfo, and A. Matilla-Duenas
Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1
Hum. Mol. Genet.,
September 1, 2007;
16(17):
2122 - 2134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. B. Schiess, C. S. Scullin, and L. D. Partridge
Neurosteroid-induced enhancement of short-term facilitation involves a component downstream from presynaptic calcium in hippocampal slices
J. Physiol.,
November 1, 2006;
576(3):
833 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Al-Ramahi, Y. C. Lam, H.-K. Chen, B. de Gouyon, M. Zhang, A. M. Perez, J. Branco, M. de Haro, C. Patterson, H. Y. Zoghbi, et al.
CHIP Protects from the Neurotoxicity of Expanded and Wild-type Ataxin-1 and Promotes Their Ubiquitination and Degradation
J. Biol. Chem.,
September 8, 2006;
281(36):
26714 - 26724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Siwach, S. D. Pophaly, and S. Ganesh
Genomic and Evolutionary Insights into Genes Encoding Proteins with Single Amino Acid Repeats
Mol. Biol. Evol.,
July 1, 2006;
23(7):
1357 - 1369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Everett and N. W. Wood
Trinucleotide repeats and neurodegenerative disease
Brain,
November 1, 2004;
127(11):
2385 - 2405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Zu, L. A. Duvick, M. D. Kaytor, M. S. Berlinger, H. Y. Zoghbi, H. B. Clark, and H. T. Orr
Recovery from Polyglutamine-Induced Neurodegeneration in Conditional SCA1 Transgenic Mice
J. Neurosci.,
October 6, 2004;
24(40):
8853 - 8861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bolivar and L. Flaherty
A Region on Chromosome 15 Controls Intersession Habituation in Mice
J. Neurosci.,
October 15, 2003;
23(28):
9435 - 9438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Michalik and C. Van Broeckhoven
Pathogenesis of polyglutamine disorders: aggregation revisited
Hum. Mol. Genet.,
October 15, 2003;
12(90002):
R173 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dewachter, D. Reverse, N. Caluwaerts, L. Ris, C. Kuiperi, C. Van den Haute, K. Spittaels, L. Umans, L. Serneels, E. Thiry, et al.
Neuronal Deficiency of Presenilin 1 Inhibits Amyloid Plaque Formation and Corrects Hippocampal Long-Term Potentiation But Not a Cognitive Defect of Amyloid Precursor Protein [V717I] Transgenic Mice
J. Neurosci.,
May 1, 2002;
22(9):
3445 - 3453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yue, H. G. Serra, H. Y. Zoghbi, and H. T. Orr
The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract
Hum. Mol. Genet.,
January 1, 2001;
10(1):
25 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Sarnyai, E. L. Sibille, C. Pavlides, R. J. Fenster, B. S. McEwen, and M. Toth
Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin1A receptors
PNAS,
December 19, 2000;
97(26):
14731 - 14736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-X. Deng and T. Siddique
Transgenic Mouse Models and Human Neurodegenerative Disorders
Arch Neurol,
December 1, 2000;
57(12):
1695 - 1702.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tarantino and M. Bucan
Dissection of behavior and psychiatric disorders using the mouse as a model
Hum. Mol. Genet.,
April 1, 2000;
9(6):
953 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lorenzetti, K. Watase, B. Xu, M. M. Matzuk, H. T. Orr, and H. Y. Zoghbi
Repeat instability and motor incoordination in mice with a targeted expanded CAG repeat in the Sca1 locus
Hum. Mol. Genet.,
March 22, 2000;
9(5):
779 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|